NUWELLIS, INC. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
NUWELLIS, INC. (NUWE) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $2.50 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-11.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-03-11
- NUWELLIS, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was $2.50M, a 25.00% increase from fiscal 2024.
- NUWELLIS, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $2.00M, a 47.37% decline from fiscal 2023.
- NUWELLIS, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $3.80M, a 11.63% decline from fiscal 2022.
- NUWELLIS, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $4.30M, a 12.24% decline from fiscal 2021.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month |
|---|---|
| 2025-12-31 | $2.50M 10-K · filed 2026-03-11 |
| 2024-12-31 | $2.00M 10-K · filed 2026-03-11 |
| 2023-12-31 | $3.80M 10-K · filed 2025-03-11 |
| 2022-12-31 | $4.30M 10-K · filed 2024-03-11 |
| 2021-12-31 | $4.90M 10-K · filed 2023-03-03 |
| 2020-12-31 | -$7.20M 10-K · filed 2022-03-03 |
| 2019-12-31 | $3.40M 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |